The Protocol Specific Research (PSR) Shared Resource of the AECCC is designated to facilitate investigator-initiated studies that require intensive data management/research nurse efforts, and which lack other sources of support. Support is requested for two nurse practitioners and two data managers. They will be under the direct supervision of Dr. Scott Wadler and Alicia Destro, Senior Data Manager for the CPDMU, who will assign personnel based on the expected intensity of the study. The PSR core support includes: intensive data management, intensive pharmacokinetic and translational studies, review of complex eligibility requirements, assurance of protocol compliance, review of early stopping rules, interactions with the pharmacy to ensure timely and proper preparation and administration of drug, communication between investigators, and patient and family education. Programs that have utilized the PSR core extensively include gene therapy, biologicals/vaccines, novel therapeutics (including Phase I drug development), bone marrow transplantation, and multidisciplinary Phase II studies. In the 1999-2000 period, there were 14 protocols that utilized the PSR shared resource, with 112 newly enrolled patients. Given the emphasis at the AECCC on translational and multidisciplinary research, and with planned faculty recruitments to expand these programs, this level of utilization will increase substantially over the next five years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-31
Application #
6615189
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-07-29
Project End
2003-06-30
Budget Start
Budget End
Support Year
31
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150

Showing the most recent 10 out of 1508 publications